Title : Association of GSTP1 and RRM1 Polymorphisms with the Response and Toxicity of Gemcitabine-cisplatin Combination Chemotherapy in Chinese Patients with Non-small Cell Lung Cancer.

Pub. Date : 2015

PMID : 26028097






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Association of GSTP1 and RRM1 Polymorphisms with the Response and Toxicity of Gemcitabine-cisplatin Combination Chemotherapy in Chinese Patients with Non-small Cell Lung Cancer. gemcitabine ribonucleotide reductase catalytic subunit M1 Homo sapiens
2 Especially, genetic polymorphism of RRM1 is more likely to be used as an important biomarker to predict the response and toxicity of gemcitabine-cisplatin combination chemotherapy in NSCLC. gemcitabine ribonucleotide reductase catalytic subunit M1 Homo sapiens